Advanced Research Technologies Inc.
Advanced Research Technologies Inc.
of Saint-Laurent, Quebec, Canada, has announced clinical trials for the SoftScan
optical breast imaging system. The device uses time-domain optical imaging to characterize
tumors as benign or malignant. Differences in optical signatures between tissues
indicate vascularization, cellularity, oxygen consumption, edema, fibrosis and remodeling.
The study will continue through 2006
at several North American centers and examine 600 to 950 volunteer patients age
25 to over 60. The company intends to present results in its submission to Health
Canada and the FDA to support its premarket approval application.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024